ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. GOOGL
5. MU
6. DFTX
7. USO
8. APGE
9. ABBV
10. NAVN

Go back to ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
Johnson & Johnson (NYSE: JNJ) Delayed: 231.29 --0 (-0%)
Previous Close $231.29    52 Week High $126.07 
Open $231.29    52 Week Low $94.28 
Day High $231.29    P/E 48.09 
Day Low $231.29    EPS $4.81 
Volume 5,338